Paul La Rosée
Schwarzwald-Baar Klinikum(DE)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Autoimmune and Inflammatory Disorders Research, Lymphoma Diagnosis and Treatment, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Recommendations for the management of hemophagocytic lymphohistiocytosis in adults(2019)1,014 cited
- → Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy(2002)901 cited
- → Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial(2016)590 cited
- → Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial(2017)369 cited
- → Current gaps in sepsis immunology: new opportunities for translational research(2019)369 cited
- → Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance(2004)335 cited
- → Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib(2003)314 cited
- → Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial(2018)244 cited
- → A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults(2017)243 cited
- → The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation(2020)242 cited